Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al.|JAMA|2019Cited by 830
JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery DiseaseMasato Nakamura, Atsushi Hirayama, Satoshi Yasuda et al.|Circulation Journal|2020Cited by 345
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeHirotoshi Watanabe, Motoaki Higuchi, Takeshi Morimoto et al.|JAMA Cardiology|2022Cited by 296
Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting StentMasahiro Natsuaki, Takeshi Kimura, Ken Kozuma et al.|Journal of the American College of Cardiology|2013Cited by 203
Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresMasahiro Natsuaki, Takeshi Morimoto, Kyohei Yamaji et al.|Journal of the American Heart Association|2018Cited by 196